Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint, page-49

unfortunately it seems the "NEU Posters" are the only ones bringing actual facts and analysis to the discussion.

All other posting seems to circle around wish-lists, innuendo's and what-ifs.

As has been stated a lot of us have been invested in Bio's for some time - and regardless of what other posters think I/we wish NTI all the success in the world (full disclosure - I have been waiting for these results to be released in order to consider take a position).

However the reality is the results are not great - the company admits they (like Neuren and others before them) cant go the trials alone, and IMO $14m cash on hand will go quicker than you think.

Im still interested to see where NTI goes from here, and the current SP actually isnt bad for an entry - however I do feel for LT holders.

All the best.